Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The GLP-1 litigation is a fast-growing lawsuit, and we expect tens of thousands of cases to be filed as more Americans take GLP-1 agonist drugs and experience harmful, serious side effects
Novo Nordisk are leaning heavily into their oral formulation of Semaglutide, Rybelsus , (Oral formulations face their own unique challenges due to the requirement to avoid extensive degradation of the drug by the digestive system), which although shows less weight loss compared to other competitors, has the convenience of not requiring injections
Patients could receive treatment once a week, much like some modern diabetes therapies
Who may face higher risk
Personal history of thyroid cancer, pancreatitis, or gallbladder disease are contraindications
